Wanbury Ltd Receives Sertraline Form II Approval from ANVISA, BRAZIL and Secures Potential Metformin DC Grade Business Opportunity

Wanbury Limited (WL) has announced that it has received Sertraline Form II approval from ANVISA, BRAZIL. This approval, in addition to the Sertraline hydrochloride Form 1 approval that WL already has, will help the company further consolidate its share of business in Brazil's market, where it currently holds a 75% market share for sertraline. Furthermore, WL has received approval from one of its largest customers for a special grade of metformin DC grade, which presents a potential business opportunity of approximately Rupees 15 crore per annum. Both the API manufacturing sites of WL, Patalganga and Tanuku, continue to comply with cGMP Rules and Regulations.